These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
444 related articles for article (PubMed ID: 32698095)
1. Multiple sclerosis following SARS-CoV-2 infection. Palao M; Fernández-Díaz E; Gracia-Gil J; Romero-Sánchez CM; Díaz-Maroto I; Segura T Mult Scler Relat Disord; 2020 Oct; 45():102377. PubMed ID: 32698095 [TBL] [Abstract][Full Text] [Related]
2. First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease. Domingues RB; Mendes-Correa MC; de Moura Leite FBV; Sabino EC; Salarini DZ; Claro I; Santos DW; de Jesus JG; Ferreira NE; Romano CM; Soares CAS J Neurol; 2020 Nov; 267(11):3154-3156. PubMed ID: 32564153 [TBL] [Abstract][Full Text] [Related]
3. [Anosmia and COVID-19]. Reinhard A; Ikonomidis C; Broome M; Gorostidi F Rev Med Suisse; 2020 Apr; 16(N° 691-2):849-851. PubMed ID: 32348051 [TBL] [Abstract][Full Text] [Related]
4. Should we expect neurological symptoms in the SARS-CoV-2 epidemic? Matías-Guiu J; Gomez-Pinedo U; Montero-Escribano P; Gomez-Iglesias P; Porta-Etessam J; Matias-Guiu JA Neurologia (Engl Ed); 2020 Apr; 35(3):170-175. PubMed ID: 32299636 [TBL] [Abstract][Full Text] [Related]
5. An Italian programme for COVID-19 infection in multiple sclerosis. Sormani MP; Lancet Neurol; 2020 Jun; 19(6):481-482. PubMed ID: 32359409 [No Abstract] [Full Text] [Related]
6. Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19. Baig AM; Sanders EC ACS Chem Neurosci; 2020 Jun; 11(12):1701-1703. PubMed ID: 32469504 [TBL] [Abstract][Full Text] [Related]
7. Role of SARS-CoV-2 neurotropism and neuroinvasion in COVID-19 patients disease severity. Grijalva-Otero I Gac Med Mex; 2020; 156(4):339-343. PubMed ID: 32831327 [TBL] [Abstract][Full Text] [Related]
8. Acute inflammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS-CoV-2. Bracaglia M; Naldi I; Govoni A; Brillanti Ventura D; De Massis P J Neurol; 2020 Nov; 267(11):3166-3168. PubMed ID: 32588185 [No Abstract] [Full Text] [Related]
9. Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients. Lizardo-Thiebaud MJ; Cervantes-Alvarez E; Limon-de la Rosa N; Tejeda-Dominguez F; Palacios-Jimenez M; Méndez-Guerrero O; Delaye-Martinez M; Rodriguez-Alvarez F; Romero-Morales B; Liu WH; Huang CA; Kershenobich D; Navarro-Alvarez N Semin Liver Dis; 2020 Aug; 40(3):321-330. PubMed ID: 32886936 [TBL] [Abstract][Full Text] [Related]
11. [Possible unregistered SARS-CoV-2 infection in a young man with anosmia and ageusia]. Stripp TK; Søndergaard J Ugeskr Laeger; 2020 Apr; 182(16):. PubMed ID: 32286214 [TBL] [Abstract][Full Text] [Related]
13. Panuveitis and Optic Neuritis as a Possible Initial Presentation of the Novel Coronavirus Disease 2019 (COVID-19). Benito-Pascual B; Gegúndez JA; Díaz-Valle D; Arriola-Villalobos P; Carreño E; Culebras E; Rodríguez-Avial I; Benitez-Del-Castillo JM Ocul Immunol Inflamm; 2020 Aug; 28(6):922-925. PubMed ID: 32870739 [TBL] [Abstract][Full Text] [Related]
14. Rehabilitation Recommendations for Multiple Sclerosis Patients during the COVID-19 Pandemic. Naser Moghadasi A; Azadvari M; Sahraian MA Arch Iran Med; 2020 Jul; 23(7):509-510. PubMed ID: 32657605 [No Abstract] [Full Text] [Related]
15. Sudden onset anosmia and dysgeusia in two patients: An early sign of SARS-CoV-2 infection. Alamri A; Oriez C; Bouilloud F; Dupuy O; Ben Hamou A Presse Med; 2020 Apr; 49(1):104027. PubMed ID: 32447056 [No Abstract] [Full Text] [Related]
17. COVID-19: A Review for the Pediatric Neurologist. Christy A J Child Neurol; 2020 Nov; 35(13):934-939. PubMed ID: 32660309 [TBL] [Abstract][Full Text] [Related]
18. Novel Coronavirus Disease (COVID-19) and Central Nervous System Complications: What Neurologist Need to Know. Paybast S; Emami A; Koosha M; Baghalha F Acta Neurol Taiwan; 2020 Mar; 29(1)():24-31. PubMed ID: 32285431 [TBL] [Abstract][Full Text] [Related]
19. Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab. Iannetta M; Cesta N; Stingone C; Malagnino V; Teti E; Vitale P; De Simone G; Rossi B; Ansaldo L; Compagno M; Spalliera I; Di Lorenzo A; Landi D; Nicoletti CG; Marfia GA; Andreoni M; Sarmati L Mult Scler Relat Disord; 2020 Oct; 45():102442. PubMed ID: 32777745 [TBL] [Abstract][Full Text] [Related]
20. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Xu X; Yu C; Qu J; Zhang L; Jiang S; Huang D; Chen B; Zhang Z; Guan W; Ling Z; Jiang R; Hu T; Ding Y; Lin L; Gan Q; Luo L; Tang X; Liu J Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1275-1280. PubMed ID: 32107577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]